Click on a tag to filter your results:
healthvaccines
infants
virus infection
northern community
physical health
COVID-19
2 record(s) found in the location "" (multi-year projects are grouped):
Not seeing the results you want? Tryadvanced search.
COVID-19 vaccination effectiveness in Indigenous peoples in the Northwest Territories
Principal Investigator: Sharma, Sangita
Licensed Year(s): 2024 2023
Summary: This licence has been issued for the scientific research application No.5465. In four Northwest Territories communities, we aim to determine the immune response to COVID-19 vaccines and how long this protection lasts in Indigenous community members. In partnership with the Tli?cho Government, the research team aim to determine COVID-19 immune protection (immunity) among community members (a...
Licensed Year(s): 2024 2023
Summary: This licence has been issued for the scientific research application No.5465. In four Northwest Territories communities, we aim to determine the immune response to COVID-19 vaccines and how long this protection lasts in Indigenous community members. In partnership with the Tli?cho Government, the research team aim to determine COVID-19 immune protection (immunity) among community members (a...
Haemophilus Influenzae type B Meningitis Control Project in the Northwest Territories.
Principal Investigator: Barreto, Luis
Licensed Year(s): 1987
Summary: A preliminary study will be undertaken to confirm the safety and the immunogenicity of the Connaught conjugate vaccine for native populations of the NWT (Phase I). This will be determined by the frequency and severity of adverse responses to three doses of the vaccine by a sample of infants 2-3 months of age drawn from Inuit and Dene populations. Parental consent will be obtained for all those in...
Licensed Year(s): 1987
Summary: A preliminary study will be undertaken to confirm the safety and the immunogenicity of the Connaught conjugate vaccine for native populations of the NWT (Phase I). This will be determined by the frequency and severity of adverse responses to three doses of the vaccine by a sample of infants 2-3 months of age drawn from Inuit and Dene populations. Parental consent will be obtained for all those in...
TOTAL PAGES: 1
